These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3659227)

  • 1. Influence of the histaminergic system on opiate-induced neurosecretion and behaviour.
    Duka T; Hoehe M; Doenicke A; Stephan U; Matussek N
    Psychoneuroendocrinology; 1987; 12(4):271-80. PubMed ID: 3659227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the menstrual cycle on neuroendocrine and behavioral responses to an opiate agonist in humans: preliminary results.
    Hoehe M
    Psychoneuroendocrinology; 1988; 13(4):339-44. PubMed ID: 2852375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human studies on the mu opiate receptor agonist fentanyl: neuroendocrine and behavioral responses.
    Hoehe M; Duka T; Doenicke A
    Psychoneuroendocrinology; 1988; 13(5):397-408. PubMed ID: 2849775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of histaminergic H1 and H2 receptors in prolactin release in humans].
    Segrestaa JM; Gueris J; Lefaucheur C; Orriere P
    Pathol Biol (Paris); 1982 Oct; 30(8):715-8. PubMed ID: 6760074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
    Zanoboni A; Galmozzi G; Marinoni S; Zanoboni-Muciaccia W
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histaminergic regulation of prolactin secretion: dose-response relationship and possible involvement of the dopaminergic system.
    Knigge U; Thuesen B; Christiansen PM
    J Clin Endocrinol Metab; 1986 Mar; 62(3):491-6. PubMed ID: 3944233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the H2 receptor antagonist cimetidine on pituitary hormones in man.
    Delitala G; Stubbs WA; Wass JA; Jones A; Williams S; Besser GM
    Clin Endocrinol (Oxf); 1979; 11(2):161-7. PubMed ID: 487614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histaminergic stimulation of prolactin secretion mediated via H1- or H2-receptors: dependence on routes of administration.
    Knigge U; Matzen S; Warberg J
    Neuroendocrinology; 1986; 44(1):41-8. PubMed ID: 2878384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between dose-responses of prolactin, thyroid stimulating hormone and growth hormone to two different histamine H-2 receptor antagonists in normal men.
    Knigge U; Wollesen F; Dejgarrd A; Thuesen B; Christiansen PM
    Clin Endocrinol (Oxf); 1981 Dec; 15(6):585-92. PubMed ID: 6276054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of H1 and H2 antagonists for chemoprophylaxis: a double-blind, placebo-controlled study in healthy volunteers.
    Doenicke A; Moss J; Toledano A; Hoernecke R; Lorenz W; Ostwald P
    J Clin Pharmacol; 1997 Feb; 37(2):140-6. PubMed ID: 9055140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine regulation of prolactin secretion through H1- and H2-receptors.
    Knigge U; Dejgaard A; Wollesen F; Thuesen B; Christiansen PM
    J Clin Endocrinol Metab; 1982 Jul; 55(1):118-22. PubMed ID: 6804481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cimetidine on pituitary function: Alterations in hormone secretion profiles.
    Valk TW; England BG; Marshall JC
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):139-49. PubMed ID: 7307288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminergic mediation of the stress-induced release of prolactin in male rats.
    Knigge U; Matzen S; Warberg J
    Neuroendocrinology; 1988 Jan; 47(1):68-74. PubMed ID: 3340272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent influence of fentanyl on prolactin, growth hormone, and mood.
    Hoehe M; Duka T; Doenicke A; Matussek N
    Neuropeptides; 1984 Dec; 5(1-3):269-72. PubMed ID: 6099509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
    Arvat E; Maccagno B; Ramunni J; Gianotti L; Di Vito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the H2 receptor antagonist ranitidine on anterior pituitary hormone secretion in man.
    Delitala G; Devilla L; Pende A; Canessa A
    Eur J Clin Pharmacol; 1982; 22(3):207-11. PubMed ID: 6125393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of histamine in suckling-induced release of oxytocin, prolactin and adrenocorticotropin in lactating rats.
    Schagen FH; Knigge U; Kjaer A; Larsen PJ; Warberg J
    Neuroendocrinology; 1996 Jun; 63(6):550-8. PubMed ID: 8793897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations with the specific mu-opiate receptor agonist fentanyl in depressive patients: growth hormone, prolactin, cortisol, noradrenaline and euphoric responses.
    Matussek N; Hoehe M
    Neuropsychobiology; 1989; 21(1):1-8. PubMed ID: 2554192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a histamine H2-receptor antagonist, cimetidine, on prolactin secretion in women].
    Masaoka K; Niibe T; Kumasaka T; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1627-33. PubMed ID: 6619615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.
    Nicholson AN; Pascoe PA; Turner C; Ganellin CR; Greengrass PM; Casy AF; Mercer AD
    Br J Pharmacol; 1991 Sep; 104(1):270-6. PubMed ID: 1686208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.